ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 100 filers reported holding ARATANA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $98,000 | -41.0% | 19,095 | -58.5% | 0.00% | – |
| Q1 2019 | $166,000 | -47.6% | 46,046 | -10.9% | 0.00% | – |
| Q4 2018 | $317,000 | +5.3% | 51,701 | +0.7% | 0.00% | – |
| Q3 2018 | $301,000 | +250.0% | 51,360 | +152.9% | 0.00% | – |
| Q2 2018 | $86,000 | +30.3% | 20,307 | +35.5% | 0.00% | – |
| Q1 2018 | $66,000 | -17.5% | 14,990 | -1.2% | 0.00% | – |
| Q4 2017 | $80,000 | -14.0% | 15,172 | 0.0% | 0.00% | – |
| Q3 2017 | $93,000 | -14.7% | 15,172 | 0.0% | 0.00% | – |
| Q2 2017 | $109,000 | +36.2% | 15,172 | 0.0% | 0.00% | – |
| Q1 2017 | $80,000 | -25.2% | 15,172 | +1.2% | 0.00% | – |
| Q4 2016 | $107,000 | -63.6% | 14,990 | -52.3% | 0.00% | – |
| Q3 2016 | $294,000 | +209.5% | 31,443 | +109.8% | 0.00% | – |
| Q2 2016 | $95,000 | +14.5% | 14,990 | 0.0% | 0.00% | – |
| Q1 2016 | $83,000 | -4.6% | 14,990 | -3.1% | 0.00% | – |
| Q4 2015 | $87,000 | -31.5% | 15,473 | +3.2% | 0.00% | – |
| Q3 2015 | $127,000 | -71.0% | 14,990 | -48.3% | 0.00% | -100.0% |
| Q2 2015 | $438,000 | -5.6% | 28,990 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $464,000 | -10.3% | 28,990 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $517,000 | +77.7% | 28,990 | 0.0% | 0.00% | – |
| Q3 2014 | $291,000 | -36.2% | 28,990 | -0.7% | 0.00% | -100.0% |
| Q2 2014 | $456,000 | -15.2% | 29,190 | +0.7% | 0.00% | 0.0% |
| Q1 2014 | $538,000 | – | 28,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|